Calyxha Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Calyxha General Information

Description

Operator of a biotech company intended to develop novel small-molecule anti-inflammatory drugs. The company develops novel therapies targeting tissue degeneration, the fundamental underlying cause of major human diseases, enabling the health industry to discover drug for neurodegenerative diseases for better future aids.

Contact Information

Website
www.calyxha.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Karl-Farkas-Gasse 22
  • Vienna, 1030
  • Austria
+43 01
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Karl-Farkas-Gasse 22
  • Vienna, 1030
  • Austria
+43 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Calyxha Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 14-Nov-2024 Completed Out of Business
1. Seed Round 04-Mar-2020 Completed Clinical Trials - Phase 1
To view Calyxha’s complete valuation and funding history, request access »

Calyxha Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Calyxha Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230225988-A1 Antiviral use of calixarenes Pending 18-Jun-2020
US-11273163-B2 Antiviral treatment Active 29-May-2020
US-11433080-B2 Antiviral treatment Active 29-May-2020
US-20210369730-A1 Antiviral treatment Active 29-May-2020
US-20220143040-A1 Antiviral treatment Active 29-May-2020 A61K31/55
To view Calyxha’s complete patent history, request access »

Calyxha Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Calyxha FAQs

  • When was Calyxha founded?

    Calyxha was founded in 2019.

  • Where is Calyxha headquartered?

    Calyxha is headquartered in Vienna, Austria.

  • What is the size of Calyxha?

    Calyxha has 3 total employees.

  • What industry is Calyxha in?

    Calyxha’s primary industry is Drug Discovery.

  • Is Calyxha a private or public company?

    Calyxha is a Private company.

  • What is Calyxha’s current revenue?

    The current revenue for Calyxha is .

  • How much funding has Calyxha raised over time?

    Calyxha has raised $1.09M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process